North Shore-LIJ

Modulate the Dose

CBS New York reports that pharmacogenomic testing can explain why some patients do not get relief from certain treatments.

The two entities also plan to work together using the data generated from the tests to do added research.

It will be the first comprehensive clinical-oriented collaboration for CSHL, and is expected to enable the institution to more quickly move its basic biomarker and therapeutic discoveries to the clinic.

Cold Spring Harbor Laboratory partners with the North Shore-LIJ Health System to pursue cancer therapeutics research.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.